GE Healthcare Demonstrates Resilience in China Post-Spin-off Despite Market Shifts-Jiangsu Yaguang Medical Devices Co., Ltd.

GE Healthcare Demonstrates Resilience in China Post-Spin-off Despite Market Shifts

Since its spin-off from General Electric in January 2023, GE Healthcare's operations in China have demonstrated notable resilience despite market fluctuations. Before the separation, GE Healthcare's China revenue was approximately $2 billion, accounting for about 14% of the division's global sales. In its first independent year, China revenue grew 10% to $2.785 billion, increasing its share of group revenue. Although revenue declined in the following year, the 2024 figure of $2.36 billion remained $360 million higher than the pre-spin-off baseline5.

This performance occurs amidst a broader context where the CEO of GE Healthcare has stated that "China is no longer the main engine of high growth," reflecting a shift in market dynamics. Nonetheless, GE Healthcare's ability to maintain revenue above pre-spin-off levels highlights the strategic importance of the Chinese market and the company's adaptive measures in a changing landscape

keyword:

GE Healthcare,China market, post-spin-off performance,market resilience,medical imaging

Recommended News

“Automation and Digital Twins Redefine Medical Device Manufacturing in 2025”

2025-12-15

“Smart Infusion Devices Transform Medication Safety and Precision in Hospitals”

2025-12-15

“AI Diagnostic Im“AI Diagnostic Imaging Software Achieves Breakthrough in Early Disease Detection”aging Software Achieves Breakthrough in Early Disease Detection”